Erratum: Loss of connective tissue growth factor as an unfavorable prognosis factor activates miR-18b by PI3K/AKT/C-Jun and C-Myc and promotes cell growth in nasopharyngeal carcinoma (Cell Death and Disease (2013) 4 (e634) DOI: 10.1038/cddis.2013.153);Loss of connective tissue growth factor as an unfavorable prognosis factor activates miR-18b by PI3K/AKT/C-Jun and C-Myc and promotes cell growth in nasopharyngeal carcinoma

Cell Death and Disease

Volumn 4, Issue 5, 2013, Pages

  Yu, X ^a   Zhen, Y ^a   Yang, H ^b   Wang, H ^a   Zhou, Y ^a   Wang, E ^c   Marincola, F M ^a   Mai, C ^a   Chen, Y ^a   Wei, H ^a   Song, Y ^a   Lyu, X ^a   Ye, Y ^a   Cai, L ^a   Wu, Q ^a   Zhao, M ^a   Hua, S ^a   Fu, Q ^a   Zhang, Y ^d   Yao, K ^a   Liu, Z ^a,d   Li, X ^a   Fang, W ^a   more..

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b GUANGDONG MEDICAL UNIVERSITY   (China)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d GUANGZHOU UNIVERSITY   (China)

Author keywords

CTGF; MiR 18b; NPC; PI3K AKT

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CONNECTIVE TISSUE GROWTH FACTOR; MICRORNA; MICRORNA 18B; MYC PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN C JUN; PROTEIN KINASE B; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER PROGNOSIS; CELL CYCLE PROGRESSION; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; MOUSE; NASOPHARYNX CARCINOMA; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STABLE EXPRESSION; UPREGULATION;

EID: 84879384573     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2013.216     Document Type: Erratum

References (33)

1. Fang W, Li X, Jiang Q, Liu Z, Yang H, Wang S et al. Transcriptional patterns, biomarkers and pathways characterizing nasopharyngeal carcinoma of Southern China. J Transl Med 2008; 6: 32.
2. Alajez NM, Shi W, Hui AB, Bruce J, Lenarduzzi M, Ito E et al. Enhancer of Zeste homolog 2 (EZH2) is overexpressed in recurrent nasopharyngeal carcinoma and is regulated by miR-26a, miR-101, and miR-98. Cell Death Dis 2010; 1: e85.
3. Liu Z, Luo W, Zhou Y, Zhen Y, Yang H, Yu X et al. Potential tumor suppressor NESG1 as an unfavorable prognosis factor in nasopharyngeal carcinoma. PLoS One 2011; 6: e27887.
4. Wang S, Fang W. Increased expression of hepatoma-derived growth factor correlates with poor prognosis in human nasopharyngeal carcinoma. Histopathology 2011; 58: 217-224.
5. Luo WR, Wu AB, Fang WY, Li SY, Yao KT. Nuclear expression of N-cadherin correlates with poor prognosis of nasopharyngeal carcinoma. Histopathology 2012; 61: 237-246.
6. Chien W, O'Kelly J, Lu D, Leiter A, Sohn J, Yin D et al. Expression of connective tissue growth factor (CTGF/CCN2) in breast cancer cells is associated with increased migration and angiogenesis. Int J Oncol 2011; 38: 1741-1747.
7. Chu CY, Chang CC, Prakash E, Kuo ML. Connective tissue growth factor (CTGF) and cancer progression. J Biomed Sci 2008; 15: 675-685.
8. Zhou ZQ, Cao WH, Xie JJ, Lin J, Shen ZY, Zhang QY et al. Expression and prognostic significance of THBS1, Cyr61 and CTGF in esophageal squamous cell carcinoma. BMC Cancer 2009; 9: 291.
9. Liu L, Li Z, Feng G, You W, Li J. Expression of connective tissue growth factor is in agreement with the expression of VEGF, VEGF-C,-D and associated with shorter survival in gastric cancer. Pathol Int 2007; 57: 712-718.
10. Bennewith KL, Huang X, Ham CM, Graves EE, Erler JT, Kambham N et al. The role of tumor cell-derived connective tissue growth factor (CTGF/CCN2) in pancreatic tumor growth. Cancer Res 2009; 69: 775-784.
11. Yang F, Tuxhorn JA, Ressler SJ, McAlhany SJ, Dang TD, Rowley DR. Stromal expression of connective tissue growth factor promotes angiogenesis and prostate cancer tumorigenesis. Cancer Res 2005; 65: 8887-8895.
12. Jia XQ, Cheng HQ, Li H, Zhu Y, Li YH, Feng ZQ et al. Inhibition of connective tissue growth factor overexpression decreases growth of hepatocellular carcinoma cells in vitro and in vivo. Chin Med J (Engl) 2011; 124: 3794-3799.
13. Croci S, Landuzzi L, Astolfi A, Nicoletti G, Rosolen A, Sartori F et al. Inhibition of connective tissue growth factor (CTGF/CCN2) expression decreases the survival and myogenic differentiation of human rhabdomyosarcoma cells. Cancer Res 2004; 64: 1730-1736.
14. Chen PP, Li WJ, Wang Y, Zhao S, Li DY, Feng LY et al. Expression of Cyr61, CTGF, and WISP-1 correlates with clinical features of lung cancer. PLoS One 2007; 2: e534.
15. Barbolina MV, Adley BP, Kelly DL, Shepard J, Fought AJ, Scholtens D et al. Downregulation of connective tissue growth factor by three-dimensional matrix enhances ovarian carcinoma cell invasion. Int J Cancer 2009; 125: 816-825.
16. Chuang JY, Yang WY, Lai CH, Lin CD, Tsai MH, Tang CH. CTGF inhibits cell motility and COX-2 expression in oral cancer cells. Int Immunopharmacol 2011; 11: 948-954.
17. Braig S, Wallner S, Junglas B, Fuchshofer R, Bosserhoff AK. CTGF is overexpressed in malignant melanoma and promotes cell invasion and migration. Br J Cancer 2011; 105: 231-238.
18. Cui L, Zhang Q, Mao Z, Chen J, Wang X, Qu J et al. CTGF is overexpressed in papillary thyroid carcinoma and promotes the growth of papillary thyroid cancer cells. Tumour Biol 2011; 32: 721-728.
19. Xie JJ, Xu LY, Wu JY, Shen ZY, Zhao Q, Du ZP et al. Involvement of CYR61 and CTGF in the fascin-mediated proliferation and invasiveness of esophageal squamous cell carcinomas cells. Am J Pathol 2010; 176: 939-951.
20. Jiang CG, Lv L, Liu FR, Wang ZN, Liu FN, Li YS et al. Downregulation of connective tissue growth factor inhibits the growth and invasion of gastric cancer cells and attenuates peritoneal dissemination. Mol Cancer 2011; 10: 122.
21. Wong YF, Cheung TH, Tsao GS, Lo KW, Yim SF, Wang VW et al. Genome-wide gene expression profiling of cervical cancer in Hong Kong women by oligonucleotide microarray. Int J Cancer 2006; 118: 2461-2469.
22. Yang MH, Lin BR, Chang CH, Chen ST, Lin SK, Kuo MY et al. Connective tissue growth factor modulates oral squamous cell carcinoma invasion by activating a miR-504/FOXP1 signalling. Oncogene 2012; 31: 2401-2411.
23. Kikuchi R, Tsuda H, Kanai Y, Kasamatsu T, Sengoku K, Hirohashi S et al. Promoter hypermethylation contributes to frequent inactivation of a putative conditional tumor suppressor gene connective tissue growth factor in ovarian cancer. Cancer Res 2007; 67: 7095-7105.
24. Chang CC, Shih JY, Jeng YM, Su JL, Lin BZ, Chen ST et al. Connective tissue growth factor and its role in lung adenocarcinoma invasion and metastasis. J Natl Cancer Inst 2004; 96: 364-375.
25. van Almen GC, Verhesen W, van Leeuwen RE, van de Vrie M, Eurlings C, Schellings MW et al. MicroRNA-18 and microRNA-19 regulate CTGF and TSP-1 expression in age-related heart failure. Aging Cell 2011; 10: 769-779.
26. Ernst A, Campos B, Meier J, Devens F, Liesenberg F, Wolter M et al. De-repression of CTGF via the miR-17-92 cluster upon differentiation of human glioblastoma spheroid cultures. Oncogene 2010; 29: 3411-3422.
27. Ohgawara T, Kubota S, Kawaki H, Kondo S, Eguchi T, Kurio N et al. Regulation of chondrocytic phenotype by micro RNA 18a: involvement of Ccn2/Ctgf as a major target gene. FEBS Lett 2009; 583: 1006-1010.
28. Salvatori B, Iosue I, Mangiavacchi A, Loddo G, Padula F, Chiaretti S et al. The microRNA-26a target E2F7 sustains cell proliferation and inhibits monocytic differentiation of acute myeloid leukemia cells. Cell Death Dis 2012; 3: e413.
29. O'Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT. C-Myc-regulated microRNAs modulate E2F1 expression. Nature 2005; 435: 839-843.
30. Reuss DE, Mucha J, Hagenlocher C, Ehemann V, Kluwe L, Mautner V et al. Sensitivity of malignant peripheral nerve sheath tumor cells to TRAIL is augmented by loss of NF1 through modulation of MYC/MAD and is potentiated by curcumin through induction of ROS. PLoS One 2013; 8: e57152.
31. Yenamandra SP, Darekar SD, Kashuba V, Matskova L, Klein G, Kashuba E. Stem cell gene expression in MRPS18-2-immortalized rat embryonic fibroblasts. Cell Death Dis 2012; 3: e357.
32. Landi MT, Zhao Y, Rotunno M, Koshiol J, Liu H, Bergen AW et al. MicroRNA expression differentiates histology and predicts survival of lung cancer. Clin Cancer Res 2010; 16: 430-441.
33. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25: 402-408.